Neurology and Therapy: 2023, vol: 12, issue: 6
- 1)- Russell Rosenberg, Rogelio Braceras, Wayne Macfadden, Shawn Candler, Jed Black, Chad Ruoff. Implications of Oxybate Dosing Regimen for Sleep, Sleep Architecture, and Disrupted Nighttime Sleep in Patients with Narcolepsy: A Commentary. Neurology and therapy. 2023, 12 (6): 1805-1820
Cited : 3Read More - 2)- Rita Sattler, Bryan J Traynor, Janice Robertson, Ludo Van Den Bosch, Sami J Barmada, Clive N Svendsen, Matthew D Disney, Tania F Gendron, Philip C Wong, Martin R Turner, Adam Boxer, Suma Babu, Michael Benatar, Michael Kurnellas, Jonathan D Rohrer, Christopher J Donnelly, Lynette M Bustos, Kendall Van Keuren-Jensen, Penny A Dacks, Marwan N Sabbagh, . Roadmap for C9ORF72 in Frontotemporal Dementia and Amyotrophic Lateral Sclerosis: Report on the C9ORF72 FTD/ALS Summit. Neurology and therapy. 2023, 12 (6): 1821-1843Cited : 8Read More
- 3)- Taoufik Alsaadi, Deeb M Kayed, Abubaker Al-Madani, Ali Mohamed Hassan, Alessandro Terruzzi, Derk Krieger, Naji Riachi, Pournamy Sarathchandran, Suhail Al-Rukn. Consensus-Based Recommendations on the Use of CGRP-Based Therapies for Migraine Prevention in the UAE. Neurology and therapy. 2023, 12 (6): 1845-1865Cited : 2Read More
- 4)- Angelo Ghezzi, R F Neuteboom. Neurofilament Light Chain in Adult and Pediatric Multiple Sclerosis: A Promising Biomarker to Better Characterize Disease Activity and Personalize MS Treatment. Neurology and therapy. 2023, 12 (6): 1867-1881Cited : 1Read More
- 5)- Arthur Esquer, Frédéric Blanc, Nicolas Collongues. Immunotherapies Targeting Amyloid and Tau Protein in Alzheimer's Disease: Should We Move Away from Diseases and Focus on Biological Targets? A Systematic Review and Expert Opinion. Neurology and therapy. 2023, 12 (6): 1883-1907Cited : 3Read More
- 6)- Scott D Newsome, Cherie Binns, Ulrike W Kaunzner, Seth Morgan, June Halper. No Evidence of Disease Activity (NEDA) as a Clinical Assessment Tool for Multiple Sclerosis: Clinician and Patient Perspectives [Narrative Review]. Neurology and therapy. 2023, 12 (6): 1909-1935Cited : 4Read More
- 7)- Jason Aldred, Eric Freire-Alvarez, Alexander V Amelin, Angelo Antonini, Bruno Bergmans, Filip Bergquist, Manon Bouchard, Kumar Budur, Camille Carroll, K Ray Chaudhuri, Susan R Criswell, Erik H Danielsen, Florin Gandor, Jia Jia, Thomas E Kimber, Hideki Mochizuki, Weining Z Robieson, Amy M Spiegel, David G Standaert, Saritha Talapala, Maurizio F Facheris, Victor S C Fung. Continuous Subcutaneous Foslevodopa/Foscarbidopa in Parkinson's Disease: Safety and Efficacy Results From a 12-Month, Single-Arm, Open-Label, Phase 3 Study. Neurology and therapy. 2023, 12 (6): 1937-1958Cited : 7Read More
- 8)- Jason Aldred, Eric Freire-Alvarez, Alexander V Amelin, Angelo Antonini, Bruno Bergmans, Filip Bergquist, Manon Bouchard, Kumar Budur, Camille Carroll, K Ray Chaudhuri, Susan R Criswell, Erik H Danielsen, Florin Gandor, Jia Jia, Thomas E Kimber, Hideki Mochizuki, Weining Z Robieson, Amy M Spiegel, David G Standaert, Saritha Talapala, Maurizio F Facheris, Victor S C Fung. Correction: Continuous Subcutaneous Foslevodopa/Foscarbidopa in Parkinson's Disease: Safety and Efficacy Results From a 12-Month, Single-Arm, Open-Label, Phase 3 Study. Neurology and therapy. 2023, 12 (6): 1959-1960Cited : 0Read More
- 9)- Crystal Watson, Dhanalakshmi Thirumalai, Arie Barlev, Eddie Jones, Sasha Bogdanovich, Kiren Kresa-Reahl. Treatment Patterns and Unmet Need for Patients with Progressive Multiple Sclerosis in the United States: Survey Results from 2016 to 2021. Neurology and therapy. 2023, 12 (6): 1961-1979Cited : 1Read More
- 10)- Noboru Imai, Yuki Isogai, Yoshiyuki Shibasaki, Masami Nakai, Miki Ishida, Xiaoping Ning, Nobuyuki Koga. Effects of Fremanezumab on Medication Overuse in Japanese Chronic Migraine Patients: Post Hoc Analysis of a Multicenter, Randomized, Double-Blind, Placebo-Controlled Trial. Neurology and therapy. 2023, 12 (6): 1981-1991Cited : 1Read More
- 11)- Shigekazu Kitamura, Takao Takeshima, Daishi Yui, Gabriel Paiva da Silva Lima, Reija Koukakis, Cheng Peng, Ryuji Yoshida, Yotaro Numachi, Miki Hasebe. Efficacy of Erenumab for Migraine Prevention in Japanese Patients with Episodic and Chronic Migraine: Results of a Post-Hoc Pooled Analysis. Neurology and therapy. 2023, 12 (6): 1993-2006Cited : 0Read More
- 12)- Mamoru Shibata, Atsuko Nihira, Yuka Tanji, Akichika Ozeki, Hideyuki Imagawa, Mika Komori. Galcanezumab Efficacy Through the Dosing Interval in Japanese Patients with Episodic Migraine: Post Hoc Analysis of a Phase 2 Randomized Trial. Neurology and therapy. 2023, 12 (6): 2007-2019Cited : 1Read More
- 13)- Yongang Li, GuiKai Ji, Mengjia Lian, Xuan Liu, Ying Xu, Yaxing Gui. Effect of PLA2G6 and SMPD1 Variants on the Lipid Metabolism in the Cerebrospinal Fluid of Patients with Parkinson's Disease: A Non-targeted Lipidomics Study. Neurology and therapy. 2023, 12 (6): 2021-2040Cited : 1Read More
- 14)- Radu Tanasescu, Nanci Frakich, I-Jun Chou, Perla Filippini, Giulio Podda, Gao Xin, Ranjithmenon Muraleedharan, Oltita Jerca, David Onion, Cris S Constantinescu. Natalizumab Treatment of Relapsing Remitting Multiple Sclerosis Has No Long-Term Effects on the Proportion of Circulating Regulatory T Cells. Neurology and therapy. 2023, 12 (6): 2041-2052Cited : 1Read More
- 15)- Agnete Skovlund Dissing, Xin Ying Lee, Ole Østerberg, Lene Hammer-Helmich. Burden of Medication Overuse in Migraine: A Cross-sectional, Population-Based Study in Five European Countries Using the 2020 National Health and Wellness Survey (NHWS). Neurology and therapy. 2023, 12 (6): 2053-2065Cited : 2Read More
- 16)- Byron J Aguilar, Donald Miller, Guneet Jasuja, Xuyang Li, Ekaterina Shishova, Maureen K O'Connor, Andrew Nguyen, Peter Morin, Dan Berlowitz, Raymond Zhang, Amir Abbas Tahami Monfared, Quanwu Zhang, Weiming Xia. Rule-Based Identification of Individuals with Mild Cognitive Impairment or Alzheimer's Disease Using Clinical Notes from the United States Veterans Affairs Healthcare System. Neurology and therapy. 2023, 12 (6): 2067-2078Cited : 5Read More
- 17)- Christopher A Hartford, Steven A Sherman, Stella Karantzoulis, Isabelle Guillemin, Michael G Phinney, Kimberly L Kelly, Kayla E Negron, Shruti M Raja, Diana Rofail. Experience of Daily Life with Generalized Myasthenia Gravis: A Qualitative Investigation and Assessment of Instrument Content Validity. Neurology and therapy. 2023, 12 (6): 2079-2099Cited : 1Read More
- 18)- Hanbin Wang, Luxuan Wang, Yanli Tan, Chuan Fang, Chunhui Li, Lijian Zhang. Identification of miRNAs Involved in Intracranial Aneurysm Rupture in Cigarette-Smoking Patients. Neurology and therapy. 2023, 12 (6): 2101-2119Cited : 0Read More
- 19)- Jiajia Yao, Rumeng Zhou, Yue Liu, Yin Liu, Qian Cao, Zuneng Lu. Predicting of Mechanical Ventilation and Outcomes by Using Models and Biomarker in Guillain-Barré Syndrome. Neurology and therapy. 2023, 12 (6): 2121-2132Cited : 0Read More
- 20)- Anne M Ryschon, Khoa N Cao, Asim Roy, Jan B Pietzsch. Cost-Effectiveness of Tonic Motor Activation (TOMAC) Therapy for Patients with Restless Legs Syndrome: An Exploratory Analysis. Neurology and therapy. 2023, 12 (6): 2133-2146Cited : 0Read More
- 21)- Yuanyuan Gao, Dan Su, Zhouya Xue, Lin Ji, Shu Wang. Association Between Serum Neurofilament Light Chain and Cognitive Performance Among Older Adults in the United States: A Cross-Sectional Study. Neurology and therapy. 2023, 12 (6): 2147-2160Cited : 3Read More
- 22)- Lisa Belter, Ilse Peterson, Jill Jarecki. Evaluating Perceived Fatigue within an Adult Spinal Muscular Atrophy Population. Neurology and therapy. 2023, 12 (6): 2161-2175Cited : 1Read More
- 23)- José E Meca-Lallana, José M Prieto González, Ana B Caminero Rodríguez, Javier Olascoaga Urtaza, Ana M Alonso, Eduardo Durán Ferreras, Raúl Espinosa, Julio Dotor, Mercedes Romera, Adrián Ares Luque, Domingo Pérez Ruiz, Carmen Calles, Miguel A Hernández, Miguel Hervás García, Amelia Mendoza Rodríguez, Yasmina Berdei Montero, Nieves Téllez, Nicolás Herrera Varó, Javier Sotoca, Silvia Presas-Rodríguez, Luis A Querol Gutierrez, Mariona Hervás Pujol, Jordi Batlle Nadal, Gisela Martín Ozaeta, Laura Gub. Effectiveness and Safety of Teriflunomide in Relapsing-Remitting Multiple Sclerosis and Improvements in Quality of Life: Results from the Real-World TERICARE Study. Neurology and therapy. 2023, 12 (6): 2177-2193Cited : 0Read More
- 24)- Pelayo Nieto-Gómez, Celia Castaño-Amores. Letter to the Editor Regarding: "Real-World Analysis Affirms the High Persistence and Adherence Observed with Diroximel Fumarate in Patients with Multiple Sclerosis". Neurology and therapy. 2023, 12 (6): 2195-2197Cited : 0Read More
- 25)- Brittney Lager, Jacob Liseno, Ivan Božin, Sarah M England, Sai L Shankar, Jason P Mendoza, James B Lewin. Response to Letter to the Editor Regarding "Real-World Analysis Affirms the High Persistence and Adherence Observed with Diroximel Fumarate in Patients with Multiple Sclerosis". Neurology and therapy. 2023, 12 (6): 2199-2203Cited : 0Read More
